|
Panacea
to commercialise NDDS for eye drops
EPP
News Bureau - Mumbai
Panacea Biotec has signed an agreement with National Research Development
Corporation, New Delhi to commercialise the know-how for an ophthalmic
formulation using nanotechnology. The know-how for the formulation
of of ocular delivery based on nanotechnology was originally developed
by Prof A N Maitra of the Department of Chemistry, University of
Delhi and it sold the rights for this technology to NRDC.
Most eye diseases are treated with topical application of solutions
administered as eye drops. One of the major problems encountered
with this is the rapid and extensive precorneal loss caused by the
drainage and high tear fluid turnover. After instillation of an
eye drop, typically less than 2-3 per cent of the applied drug penetrates
the cornea and reaches the intraocular tissues. The new formulation
would provide high and sustained release of drugs to the cornea
with an enhanced corneal permeability.
|
